Table 2.
Characteristics | All Patients | Patients Without CKD | Patients With CKD | P Value |
---|---|---|---|---|
N | 7059 | 5478 (78%) | 1581 (22%) | |
Age (y), mean (SD) | 66.3 (15.7) | 63.1 (15.7) | 77.3 (9.7) | <0.001 |
Female sex, x/n (%) | 2580 (37%) | 1884 (34%) | 696 (44%) | <0.001 |
NSTE‐AMI, x/n (%) | 1375/7059 (19%) | 929/5478 (17%) | 446/1581 (28%) | <0.001 |
Laboratory results | ||||
eGFR (mL/[min·1.73 m2]), mean (SD) | 67.5 (26.6) | 73.5 (25.2) | 46.4 (19.4) | <0.001 |
Initial hs‐cTnT (ng/L), median (IQR) | 12.4 (5.3, 32.9) | 9.2 (5.0, 23.5) | 29.7 (16.1, 66.6) | <0.001 |
Second hs‐cTnT (ng/L), median (IQR) | 13.3 (5.2, 43.6) | 9.4 (5.0, 28.0) | 36.4 (17.3, 106.6) | <0.001 |
Cardiovascular risk factor | ||||
Hypertension, x/n (%) | 4675/7059 (66%) | 3298/5478 (60%) | 1377/1581 (87%) | <0.001 |
Diabetes mellitus, x/n (%) | 1490/7059 (21%) | 889/5478 (16%) | 601/1581 (38%) | <0.001 |
Baseline characteristics of the clinical data set. Data presented as cases/number (percentage), mean (SD), or median (IQR), as indicated. CKD indicates chronic kidney disease; eGFR, estimated glomerular filtration rate; hs‐cTnT, high‐sensitivity cardiac troponin T; IQR, interquartile range; NSTE‐AMI, non–ST‐segment elevation acute myocardial infarction.